Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million individual investors worldwide.

• Investors may be wondering whether Cencora is attractively priced after its recent run and pullback, or if the stock is now reflecting too much optimism.

• The share price closed at US$309.93, with a 3.3% decline over the last 7 days and a 16.7% decline over the last 30 days. This is set against a 12.2% return over 1 year and very strong returns over 3 and 5 years.

• Recent coverage has focused on Cencora as a key healthcare distributor and supply chain player, with attention on how it fits into broader discussions around drug distribution and healthcare cost management. This context has…